ASH Ashland Inc. Common Stock

Ashland's shares have gained 30.2% in six months as cost cuts, portfolio optimization and a $1-billion buyback support returns.

Ashland (NYSE:ASH) has long anchored its investment thesis on consistent operating cash flow generation, high free cash flow conversion routinely exceeding 90%, and disciplined balance sheet capital allocation. Even in an elevated interest rate environment where borrowing costs penalize balance sheet expansion, strategically increasing leverage remains a prudent move when capital is directed into high-barrier, […]

Ashland Inc. (NYSE:ASH) has long anchored its investment thesis on dependable operating cash flow generation, high free cash flow conversion, and disciplined balance sheet capital allocation. Much like how peers in the broader specialty materials sector deploy targeted capital into mission-critical niches, similar to how Air Products is quietly cornering high-margin chip fab supply chains, […]

Ashland (ASH) has put a new US$1b share repurchase plan on the table, doubling its prior authorization as management leans into cost savings and portfolio pruning to support margins and free cash flow. Recent trading has been soft, with Ashland’s share price down 5.24% over the past 30 days. However, the year-to-date share price return of 16.57% and 1-year total shareholder return of 38.46% point to momentum building around the cost savings and buyback story. Compare Ashland’s buyback and...

Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

Omega Healthcare, Clorox and Ashland have each raised dividends and offer growth catalysts, making them worth a look for investors seeking both income and total return potential.

Avient's Q2 earnings rise 20% as organic sales growth and margin expansion fuel a beat, prompting higher 2026 earnings and EBITDA guidance.

Tronox's Q2 sales rise 19% on stronger TiO2 and zircon volumes, but higher production, freight and other costs deepen its adjusted loss.

Koppers' Q2 results beat estimates as strong PC volumes and utility pole demand offset pricing pressure and higher costs.

What Ashland’s latest quarter tells you about the business Ashland (ASH) reported fiscal third quarter results that combined higher sales and positive net income with lower adjusted earnings guidance. The update, along with reaffirmed full year revenue targets, gives investors fresh context for the stock. See our latest analysis for Ashland. The earnings guidance reset and fresh governance steps, including the new Capital Allocation Advisory Committee, seem to have sharpened attention on...

Ashland Inc (ASH) reports a 7% increase in revenue, driven by robust performance in Life Sciences and Personal Care, despite facing production and cost pressures.

Ashland (NYSE:ASH) reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowerin

Moby summary of Ashland Inc.'s Q3 2026 earnings call

ASH's Q3 sales beat estimates as volume growth lifted all segments, but adjusted earnings missed and the company lowered its fiscal 2026 EPS growth outlook.

Ashland (ASH) delivered earnings and revenue surprises of -0.97% and +2.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Minerals Technologies (MTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.